Visualization of small lesions
Visualization of small lesions is essential for clinicians to diagnose, stage and monitor therapy in oncology patients*. Unmet needs in molecular imaging include detection of small lesions, low dose and fast scans, and clear separation of responders vs. non-responders to therapy.
Philips Vereos digital PET/CT improves detectability and characterization of small lesions relative to the same patient acquired on analog PET/CT. As the first and only true digital PET/CT system offering, Vereos Digital PET/CT is clinically proven to reveal small lesions, enabling a path to improved diagnosis, staging and treatment monitoring.
In this case, Vereos reveals a lung lesion that was not visualized on the Gemini TF analog system. The improved detectability of small lung lesions with Vereos digital PET/CT could have a significant impact on the staging of the patient, affecting the patient management pathway and determining timely response to treatment.
* Hussain T, Nguyen QT. Molecular Imaging for Cancer Diagnosis and Surgery. Advanced drug delivery reviews. 2014;66:90-100.